The Effects of Continuous Positive Airway Pressure on Prehypertension and Masked Hypertension in Men With Severe Obstructive Sleep Apnea


Autoria(s): DRAGER, Luciano F.; PEDROSA, Rodrigo P.; DINIZ, Patricia M.; DIEGUES-SILVA, Luzia; MARCONDES, Bianca; COUTO, Roberta B.; GIORGI, Dante M. A.; KRIEGER, Eduardo M.; LORENZI-FILHO, Geraldo
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Obstructive sleep apnea and hypertension are common conditions that frequently coexist. Continuous positive airway pressure (CPAP) reduces blood pressure in patients with obstructive sleep apnea and sustained hypertension. However, the impact of CPAP on patients with obstructive sleep apnea and prehypertension and masked hypertension, conditions associated with increased cardiovascular risk, is unknown. Thirty-six male patients (age, 43 +/- 7 years; body mass index, 28.8 +/- 3.0 kg/m(2)) with untreated severe obstructive sleep apnea (apnea-hypopnea index, 56 +/- 22 events/hr on polysomnography) with diagnostic criteria for prehypertension and/or masked hypertension, based on office and 24-hour ambulatory blood pressure monitoring, respectively, were studied. The patients randomized to no treatment (control; n=18) or CPAP (n=18) for 3 months had similar frequency of prehypertension and masked hypertension at study entry. There were no significant changes in blood pressure in patients randomized to the control group. In contrast, patients randomized to CPAP presented significant reduction in office systolic (from 126 +/- 5 to 121 +/- 7 mm Hg; P=0.001) and a trend for diastolic blood pressure (from 75 +/- 7 to 73 +/- 8 mm Hg; P=0.08) as well as a significant decrease in daytime and nighttime systolic and diastolic blood pressure (P < 0.05 for each comparison). There was a significant reduction in the frequency of prehypertension (from 94% to 55%; P=0.02) and masked hypertension (from 39% to 5%; P=0.04) only in the CPAP group. In conclusion, effective CPAP therapy promotes significant reduction in the frequency of prehypertension and masked hypertension by promoting significant blood pressure reductions in patients with severe obstructive sleep apnea. (Hypertension. 2011;57[part 2]:549-555.)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Fundacao E. J. Zerbini

Identificador

HYPERTENSION, v.57, n.3, p.549-U365, 2011

0194-911X

http://producao.usp.br/handle/BDPI/22847

10.1161/HYPERTENSIONAHA.110.165969

http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.165969

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

Hypertension

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #blood pressure #cardiovascular disease #CPAP #hypertension #masked hypertension #prehypertension #sleep apnea #AMBULATORY BLOOD-PRESSURE #WHITE-COAT HYPERTENSION #EARLY SIGNS #FOLLOW-UP #ATHEROSCLEROSIS #RECOMMENDATIONS #PREVALENCE #PROGNOSIS #HYPOPNEA #IMPACT #Peripheral Vascular Disease
Tipo

article

original article

publishedVersion